DZ Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-166,203
| Closed | -$4.72M | – | 1241 |
|
|
2023
Q1 | $4.72M | Sell |
166,203
-63,668
| -28% | -$1.81M | 0.01% | 446 |
|
|
2022
Q4 | $6.72M | Sell |
229,871
-55,740
| -20% | -$1.63M | 0.01% | 393 |
|
|
2022
Q3 | $7.55M | Sell |
285,611
-8,383
| -3% | -$221K | 0.01% | 354 |
|
|
2022
Q2 | $13.1M | Buy |
293,994
+122,898
| +72% | +$5.46M | 0.02% | 261 |
|
|
2022
Q1 | $8.47M | Buy |
171,096
+165,770
| +3,112% | +$8.2M | 0.01% | 377 |
|
|
2021
Q4 | $272K | Hold |
5,326
| – | – | ﹤0.01% | 870 |
|
|
2021
Q3 | $297K | Buy |
+5,326
| New | +$297K | ﹤0.01% | 825 |
|
|
2020
Q2 | – | Sell |
-4,352
| Closed | -$200K | – | 937 |
|
|
2020
Q1 | $200K | Buy |
4,352
+1,003
| +30% | +$46.1K | ﹤0.01% | 656 |
|
|
2019
Q4 | $201K | Sell |
3,349
-1,003
| -23% | -$60.2K | ﹤0.01% | 648 |
|
|
2019
Q3 | $246K | Sell |
4,352
-98,716
| -96% | -$5.58M | ﹤0.01% | 629 |
|
|
2019
Q2 | $5.74M | Sell |
103,068
-2,530
| -2% | -$141K | 0.02% | 335 |
|
|
2019
Q1 | $5.33M | Buy |
105,598
+6,140
| +6% | +$310K | 0.02% | 337 |
|
|
2018
Q4 | $3.9M | Sell |
99,458
-13,499
| -12% | -$529K | 0.02% | 373 |
|
|
2018
Q3 | $7.83M | Sell |
112,957
-9,477
| -8% | -$657K | 0.03% | 301 |
|
|
2018
Q2 | $9.26M | Buy |
122,434
+521
| +0.4% | +$39.4K | 0.03% | 289 |
|
|
2018
Q1 | $6.42M | Buy |
121,913
+29,166
| +31% | +$1.54M | 0.02% | 351 |
|
|
2017
Q4 | $4.95M | Buy |
92,747
+3,086
| +3% | +$165K | 0.02% | 368 |
|
|
2017
Q3 | $5.35M | Buy |
+89,661
| New | +$5.35M | 0.02% | 357 |
|